2AV-27718-45481
2 vaccinations
1 coded response
9 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 440 / OH
- Registered
- 2021-02-03
- Relationship
- Self
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-04
Dose 1 — Moderna
-
2021-02-03
Registered in v-safe
-
2021-02-03
Dose 2 — Moderna
- 2021-02-03
-
2021-02-04
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-04
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-17
- 2021-02-26
-
2021-08-04
Survey response — 6 months, dose 2MedDRA: Malaise, Nasopharyngitis — Feeling: GoodFree text: I have gotten sick three times since I had my last vaccine with a cold.MedDRA releases: 2021-09,2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-04 | Moderna | |
| 2 | 2021-02-03 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-02-04 | priority 2/3 |
Free text
Release 9 — 6 months, dose 2
Symptoms: I have gotten sick three times since I had my last vaccine with a cold.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Malaise | ✓ | · | ✓ |
| SD | Nasopharyngitis | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release